References
- Hartwell LH and Weinert TA (1989) Checkpoints: controls that ensure the order of cell cycle events. Science 246, 629-634 https://doi.org/10.1126/science.2683079
- Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB (1992) Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci U S A 89, 7491-7495 https://doi.org/10.1073/pnas.89.16.7491
- Bunz F, Dutriaux A, Lengauer C et al (1998) Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282, 1497-1501 https://doi.org/10.1126/science.282.5393.1497
- Lanni JS and Jacks T (1998) Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol Cell Biol 18, 1055-1064 https://doi.org/10.1128/MCB.18.2.1055
- Khan S and Wahl G (1998) p53 and pRb prevent rereplication in response to microtubule inhibitors by mediating a reversible G1 arrest. Cancer Res 58, 396-401
- Di Leonardo A, Khan S, Linke S, Greco V, Seidita G and Wahl G (1997) DNA rereplication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRb function. Cancer Res 57, 1013-1019
- Andreassen PR, Lohez OD, Lacroix FB and Margolis RL (2001) Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1. Mol Biol Cell 12, 1315-1328 https://doi.org/10.1091/mbc.12.5.1315
- Chae HD, Choi TS, Kim BM, Jung JH, Bang YJ and Shin DY (2005) Oocyte-based screening of cytokinesis inhibitors and identification of pectenotoxin-2 that induces Bim/Bax-mediated apoptosis in p53-deficient tumors. Oncogene 24, 4813-4819 https://doi.org/10.1038/sj.onc.1208640
- Yun UJ, Park HD and Shin DY (2006) p53 prevents immature escaping from cell cycle G2 checkpoint arrest through inhibiting cdk2-dependent NF-Y phosphorylation. Cancer Res Treat 38, 224-228 https://doi.org/10.4143/crt.2006.38.4.224
- Cheng M, Olivier P, Diehl JA et al (1999) The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 18, 1571-1583 https://doi.org/10.1093/emboj/18.6.1571
- Carrano AC, Eytan E, Hershko A, Pagano M (1999) SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1, 193-199 https://doi.org/10.1038/12013
- Frescas D and Pagano M (2008) Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat Rev Cancer 8, 438-449 https://doi.org/10.1038/nrc2396
- Traub F, Mengel M, Luck HJ, Kreipe HH and von Wasielewski R (2006) Prognostic impact of Skp2 and p27 in human breast cancer. Breast Cancer Res Treat 99, 185-191 https://doi.org/10.1007/s10549-006-9202-3
- Sutterluty H, Chatelain E, Marti A et al (1999) p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat Cell Biol 1, 207-214 https://doi.org/10.1038/12027
- Lin HK, Chen Z, Wang G et al (2010) Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence. Nature 464, 374-379 https://doi.org/10.1038/nature08815
- Chae HD, Kim SY, Park SE, Kim J and Shin DY (2012) p53 and DNA-dependent protein kinase catalytic subunit independently function in regulating actin damage-induced tetraploid G1 arrest. Exp Mol Med 44, 236-240 https://doi.org/10.3858/emm.2012.44.3.018
- Chae H, Kim B, Yun U and Shin D (2008) Deregulation of Cdk2 causes Bim-mediated apoptosis in p53-deficient tumors following actin damage. Oncogene 27, 4115-4121 https://doi.org/10.1038/onc.2008.46
- Chae HD, Choi TS, Kim BM, Jung JH, Bang YJ and Shin DY (2005) Oocyte-based screening of cytokinesis inhibitors and identification of pectenotoxin-2 that induces Bim/Baxmediated apoptosis in p53-deficient tumors. Oncogene 24, 4813-4819 https://doi.org/10.1038/sj.onc.1208640
- Amati B and Vlach J (1999) Kip1 meets SKP2: new links in cell-cycle control. Nat Cell Biol 1, E91-93 https://doi.org/10.1038/12087
- Wei W, Ayad NG, Wan Y, Zhang GJ, Kirschner MW and Kaelin WG Jr (2004) Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature 428, 194-198 https://doi.org/10.1038/nature02381
- Ganiatsas S, Dow R, Thompson A, Schulman B and Germain D (2001) A splice variant of Skp2 is retained in the cytoplasm and fails to direct cyclin D1 ubiquitination in the uterine cancer cell line SK-UT. Oncogene 20, 3641-3650 https://doi.org/10.1038/sj.onc.1204501
- Chae HD, Yun J, Bang YJ and Shin DY (2004) Cdk2-dependent phosphorylation of the NF-Y transcription factor is essential for the expression of the cell cycleregulatory genes and cell cycle G1/S and G2/M transitions. Oncogene 23, 4084-4088 https://doi.org/10.1038/sj.onc.1207482
- Jung MS, Jin DH, Chae HD et al (2004) Bcl-xL and E1B-19K proteins inhibit p53-induced irreversible growth arrest and senescence by preventing reactive oxygen species-dependent p38 activation. J Biol Chem 279, 17765-17771 https://doi.org/10.1074/jbc.M305015200
- Park M, Chae HD, Yun J et al (2000) Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest. Cancer Res 60, 542-545
Cited by
- Volasertib Enhances Sensitivity to TRAIL in Renal Carcinoma Caki Cells through Downregulation of c-FLIP Expression vol.18, pp.12, 2017, https://doi.org/10.3390/ijms18122568
- Angelicin potentiates TRAIL-induced apoptosis in renal carcinoma Caki cells through activation of caspase 3 and down-regulation of c-FLIP expression vol.79, pp.1, 2017, https://doi.org/10.1002/ddr.21414
- Maritoclax Enhances TRAIL-Induced Apoptosis via CHOP-Mediated Upregulation of DR5 and miR-708-Mediated Downregulation of cFLIP vol.23, pp.11, 2018, https://doi.org/10.3390/molecules23113030
- HSP70 Acetylation Prevents Combined mTORC1/2 Inhibitor and Curcumin Treatment-Induced Apoptosis vol.23, pp.11, 2018, https://doi.org/10.3390/molecules23112755
- Cepharanthine Enhances TRAIL-Mediated Apoptosis Through STAMBPL1-Mediated Downregulation of Survivin Expression in Renal Carcinoma Cells vol.19, pp.10, 2018, https://doi.org/10.3390/ijms19103280
- mTORC1/2 inhibitor and curcumin induce apoptosis through lysosomal membrane permeabilization-mediated autophagy vol.37, pp.38, 2018, https://doi.org/10.1038/s41388-018-0345-6
- Z-FL-COCHO, a cathepsin S inhibitor, enhances oxaliplatin-mediated apoptosis through the induction of endoplasmic reticulum stress vol.50, pp.8, 2018, https://doi.org/10.1038/s12276-018-0138-6
- Involvement of Up-Regulation of DR5 Expression and Down-Regulation of c-FLIP in Niclosamide-Mediated TRAIL Sensitization in Human Renal Carcinoma Caki Cells vol.23, pp.9, 2018, https://doi.org/10.3390/molecules23092264
- Garcinol Enhances TRAIL-Induced Apoptotic Cell Death through Up-Regulation of DR5 and Down-Regulation of c-FLIP Expression vol.23, pp.7, 2018, https://doi.org/10.3390/molecules23071614